NASDAQ: IBRXImmunitybio Inc Stock Ownership - Who owns Immunitybio?
Insider buying vs selling
Have Immunitybio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Christobel Selecky | Director | 2026-01-20 | 25,000 | $7.51 | $187.65kSell |
| Barry J. Simon | Director | 2026-01-20 | 76,967 | $6.54 | $503.36kSell |
| Barry J. Simon | Director | 2026-01-20 | 75,000 | $7.88 | $590.93kSell |
| Christobel Selecky | Director | 2026-01-20 | 25,000 | $2.98 | $74.50kBuy |
| Christobel Selecky | Director | 2026-01-16 | 50,000 | $2.98 | $149.00kBuy |
| Christobel Selecky | Director | 2026-01-16 | 50,000 | $5.00 | $250.00kSell |
| David C. Sachs | Chief Financial Officer | 2025-12-31 | 15,435 | $1.98 | $30.56kSell |
| Richard Adcock | CEO President | 2025-12-31 | 17,510 | $1.98 | $34.67kSell |
| Patrick Soonshiong | Founder Executive Chairman Global Chief Scientific and Medical Officer | 2025-02-22 | 42,071 | $3.42 | $143.88kSell |
| Regan J. Lauer | Chief Accounting Officer | 2025-02-22 | 1,669 | $3.42 | $5.71kSell |
IBRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IBRX insiders and whales buy or sell their stock.
IBRX Shareholders
What type of owners hold Immunitybio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Patrick Soonshiong | 7.12% | 70,129,334 | $443.92M | Insider |
| Vanguard Group Inc | 2.81% | 27,655,205 | $175.06M | Institution |
| Blackrock Inc | 2.01% | 19,810,963 | $125.40M | Institution |
| Jane Street Group LLC | 1.30% | 12,835,579 | $81.25M | Institution |
| State Street Corp | 1.15% | 11,315,813 | $71.63M | Institution |
| Geode Capital Management LLC | 0.70% | 6,890,065 | $43.61M | Institution |
| Heights Capital Management Inc | 0.67% | 6,565,709 | $41.56M | Institution |
| Woodline Partners LP | 0.54% | 5,297,725 | $33.53M | Institution |
| Morgan Stanley | 0.34% | 3,373,570 | $21.35M | Institution |
| Barry J. Simon | 0.32% | 3,112,747 | $19.70M | Insider |
IBRX vs Biotech Stocks
Immunitybio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.